06 March 2026

Champalimaud Foundation and Universidade Católica Portuguesa establish partnership to strengthen biomedical research in Portugal

The agreement establishes a long-term framework for collaboration between the two institutions, creating a model that brings university research closer to one of the country’s most advanced scientific infrastructures while fostering the development of new joint initiatives in biomedicine and interdisciplinary research.

04 March 2026

Can the brain sense cancer? Up to $25M awarded to a team including the Champalimaud Foundation to explore a new frontier in oncology

Led by the Francis Crick Institute in the UK, the team brings together clinicians, scientists and patient advocates, with researchers spanning eight institutions across four countries. The award is funded jointly by Cancer Research UK and the National Cancer Institute in the US, two of the world’s largest cancer research funders, through the global Cancer Grand Challenges initiative. It marks the first time this prestigious international award has been granted to a Portuguese institution.

26 February 2026

Champalimaud Foundation and Instituto Superior Técnico Join Forces to Lead Research in Neurorobotics

The Champalimaud Foundation (CF) and Instituto Superior Técnico (IST) have established a five-year strategic partnership to create a Neurorobotics Laboratory within the CF Neurotechnology Warehouse. Signed on 18 February, the agreement brings together two of Portugal’s leading research institutions with the goal of advancing the understanding of intelligence - both biological and artificial - at the convergence of brain science, robotics and artificial intelligence.

Medica AI 2026

Healthcare is entering a decisive decade.

Artificial Intelligence (AI) is no longer a promise on the horizon – it is already transforming diagnostics, treatment, research, education and health systems worldwide. The real challenge we now face is not whether AI will change healthcare, but how we design that transformation responsibly, sustainably and at scale.

11 February 2026

Different Visual Experiences Give Rise to Different Neural Wiring

The visual system is hierarchically organised into different areas. The lower visual areas see small parts of the visual field, and they are sensitive to very simple features, such as edges and their orientation. Higher up the hierarchy, the visual areas start encoding more abstract representations of the world, expanding their visual field to respond to stimuli such as objects and faces.  

10 February 2026

Controlled “Oxidative Spark”: A Surprising Ally in Brain Repair

Oxidative stress is a direct consequence of an excess in the body of so-called “free radicals” – reactive, unstable molecules that contain oxygen. Free radicals are normal metabolic by-products and also help to relay signals in the body. In turn, oxidative stress (an overload of these molecules) can be caused by lifestyle, environmental and biological factors such as smoking, high alcohol consumption, poor diet, stress, pollution, radiation, industrial chemicals, and chronic inflammation.

Defining the Roadmap for Spinal Cord Regeneration Using the Spiny Mouse

Host

Christa Rhiner, PhD, Stem Cells and Regeneration Lab


Venue

Seminar Room

28 Jan. 2026

Technician (Preclinical MRI Lab)

Research
Application Starts: 28 Jan. 2026

 

[THIS CALL IS NOW CLOSED]

 

29 January 2026

A Substantial Proportion of Locally Advanced Rectal Cancers Can Be Treated Directly by Surgery

Currently, the reference standard treatment for locally advanced rectal cancer, meaning tumours that have grown deeper into the layers of the rectal wall and/or involved nearby lymph nodes, but have not yet spread to the rest of the body – is to submit patients to chemotherapy and radiotherapy before surgery. This “total neoadjuvant therapy” reduces the risk of the cancer coming back in the rectum and can lower the risk of metastases, but has a cost for the patients because of the detrimental effects of radiation. 

19 Jan. 2026

PhD Position (Neuropsychiatry Unit & INTEGRATE Consortium)

Research
Application Starts: 19 Jan. 2026

Offer Description

As a partner institution of the INTEGRATE Consortium and the PsyPal Consortium, we are recruiting a PhD student in the topic of 'Psychotherapy process and psychological intervention techniques in psychedelic therapy: safety and efficacy'.This student will join the Neuropsychiatry Unit, supervised by Albino J. Oliveira-Maia and Carolina Seybert. 

Subscribe to Research Groups
Loading
Please wait...